Floatz logo

Dpx-E7 Vaccine

Cancer of Cervix

Dana-Farber Cancer InstitutevaccinePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

61 Active assets in the Cancer of Cervix cohort.

Asset / SponsorPhaseRating
Carboplatin
Advenchen Laboratories, LLC
Phase 3BB
Gardasil 9 Vaccine
Eunice Dube
Phase 4BB
Hepatitis B Virus Vaccine
Eunice Dube
Phase 4BB
Hycamtin
Advenchen Laboratories, LLC
Phase 3BB
Pembrolizumab
Mayo Clinic
Phase 2BB

View all 50 →

Same molecule, other indications

Dpx-E7 Vaccine is also rated in:

head and neck cancerDormant
CCC
Indicative ·
52 / 100
View asset →
anal carcinomaDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →